Anthony T Moore Selected Research

Cone Opsins

11/2014	Three different cone opsin gene array mutational mechanisms with genotype-phenotype correlation and functional investigation of cone opsin variants.
3/2013	X-linked cone dystrophy and colour vision deficiency arising from a missense mutation in a hybrid L/M cone opsin gene.
1/2012	A novel missense mutation in both OPN1LW and OPN1MW cone opsin genes causes X-linked cone dystrophy (XLCOD5).
7/2010	X-linked cone dystrophy caused by mutation of the red and green cone opsins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony T Moore Research Topics

Disease

26	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 08/2005
22	Retinal Dystrophies 10/2022 - 03/2008
21	Atrophy 11/2019 - 08/2005
14	Retinitis Pigmentosa (Pigmentary Retinopathy) 06/2019 - 01/2002
12	Cataract (Cataracts) 01/2022 - 05/2009
9	Retinal Degeneration 01/2021 - 06/2010
8	Cone-Rod Dystrophies 11/2019 - 09/2005
7	Vision Disorders (Hemeralopia) 12/2017 - 05/2006
6	Cone Dystrophy 02/2014 - 06/2004
5	Color Vision Defects (Color Blindness) 01/2019 - 07/2010
4	Myopia 10/2022 - 04/2009
4	Vitelliform Macular Dystrophy 01/2021 - 10/2004
4	Leber Congenital Amaurosis 01/2018 - 03/2010
4	Disease Progression 01/2017 - 12/2011
3	Retinoschisis (Retinoschisis, Juvenile) 12/2022 - 06/2010
3	Stargardt Disease 11/2014 - 12/2011
3	congenital stationary Night blindness 12/2012 - 02/2003
2	Apraxias (Dyspraxia) 10/2022 - 12/2017
2	Optic Atrophy 12/2021 - 04/2010
2	Microcephaly 11/2019 - 09/2016
2	Coloboma (Colobomas) 01/2018 - 02/2014
2	Wounds and Injuries (Trauma) 11/2016 - 01/2016
2	Blindness (Hysterical Blindness) 01/2016 - 05/2015
2	Eye Diseases (Eye Disease) 01/2016 - 11/2014
2	Prolonged Electroretinal Response Suppression 12/2015 - 01/2010
2	Telangiectasis (Telangiectasia) 06/2015 - 06/2011
2	Macular Edema 02/2015 - 03/2012
2	Early Onset Severe Retinal Dystrophy 01/2015 - 05/2008
2	Choroidal Neovascularization 03/2014 - 02/2006
2	Blue cone monochromatism 12/2013 - 12/2012
1	Inflammation (Inflammations) 12/2022
1	Uveitis 12/2022
1	Retinal Detachment (Retinal Detachments) 10/2022
1	Neovascular Glaucoma 10/2022
1	Hemorrhage 05/2021
1	Familial Exudative Vitreoretinopathies 05/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Muscular Diseases (Myopathy) 11/2020
1	Microphthalmos 01/2020
1	Hamartoma 01/2019
1	Neoplasms (Cancer) 01/2019
1	Ocular Albinism 03/2018
1	Retinal Diseases 03/2018
1	Cleft Lip (Harelip) 01/2018
1	Coloboma of optic nerve 01/2018
1	Photophobia (Light Sensitivity) 01/2018
1	Hyponatremia 01/2018
1	Exotropia (Exophoria) 01/2018
1	Acidosis 01/2018
1	Diarrhea 01/2018
1	Cysts 01/2018
1	Cerebellar Ataxia (Dysmetria) 12/2017
1	Intellectual Disability (Idiocy) 12/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2017
1	Seizures (Absence Seizure) 12/2017
1	Sclerosis 10/2017
1	Retinal Hemorrhage 10/2017
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2017
1	Cardiomyopathies (Cardiomyopathy) 09/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2017

Drug/Important Bio-Agent (IBA)

66	Retinaldehyde (Retinal)IBA 10/2022 - 02/2003
18	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2002
13	Retinal Pigments (Pigments, Visual)IBA 02/2017 - 08/2005
7	Nonsense Codon (Nonsense Mutation)IBA 04/2015 - 06/2004
6	Complement Factor H (Factor H)IBA 01/2021 - 02/2006
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2009
4	Cone OpsinsIBA 11/2014 - 07/2010
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 06/2010
3	NucleotidesIBA 01/2019 - 01/2016
3	AC133 AntigenIBA 11/2014 - 08/2008
3	Complement C3 (C3 Complement)IBA 11/2013 - 08/2007
2	Crystallins (Crystallin)IBA 11/2020 - 05/2009
2	Phosphotransferases (Kinase)IBA 01/2018 - 12/2014
2	ConnexinsIBA 01/2018 - 12/2009
2	Protein Isoforms (Isoforms)IBA 01/2017 - 06/2011
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 10/2016
2	c-Mer Tyrosine KinaseIBA 01/2017 - 03/2010
2	RNA Precursors (Precursor, mRNA)IBA 09/2016 - 01/2002
2	TubulinIBA 04/2015 - 05/2014
2	lecithin-retinol acyltransferaseIBA 01/2015 - 06/2012
2	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 02/2014 - 09/2006
2	Dyneins (Dynein)IBA 01/2014 - 11/2013
2	Complement System Proteins (Complement)IBA 02/2012 - 08/2007
2	Apolipoproteins E (ApoE)IBA 12/2011 - 06/2011
2	PeripherinsIBA 12/2010 - 09/2005
2	RNA Splicing FactorsIBA 05/2010 - 01/2002
1	laminin 1IBA 10/2022
1	Mitochondrial DNA (mtDNA)IBA 12/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2019
1	Codon (Codons)IBA 03/2018
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2018
1	SodiumIBA 01/2018
1	Chloride Channels (Chloride Channel)IBA 01/2018
1	Thyroid HormonesIBA 09/2017
1	CarbimazoleIBA 09/2017
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2017

Therapy/Procedure

9	Therapeutics 12/2022 - 09/2009
4	Lasers (Laser) 05/2021 - 11/2016
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2017